Two-year cancer-DNA-fragment screening blood test trial to start in England to assess sensitivity and specificity of early detection of numerous cancer types. If successful, it could lead to treatment of once difficult-to-detect early cancers.

Medical Mythbusting Commentary for September 20, 2021

World’s Largest Trial Of “Game-Changer” Early Cancer Test Begins In UK